DACLA®

Dacla® is a Direct-Acting Anti-viral (DAA) and is indicated in combination with other drugs for the treatment of chronic hepatitis C virus (HCV) infection in adults For activity in depending on the hepatitis C virus (HCV) genotype,

Additional information

DCI

DACLATASVIR

Dosage

60 mg

Trade name

DACLA®

Name of the originator

DACLINSA®

Presentation

28 tablets

Specialty

Hépatologie-AAD

See also